Form 4 holding
Chief Medical Officer
Acrivon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 38,817
- Estimated value
- $53,955
- Report date
- 18 May 2026
- Price
- $1.39
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|